We applaud Dr. Nacca et al. for publishing their case of ADB-FUBINACA body packing
associated with measured serum concentrations (
1
). The case is very interesting, and we seek a few clarifications regarding the patient's
presentation and care.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Coma, seizures, atrioventricular block, and hypoglycemia in an ADB-FUBINACA body-packer.J Emerg Med. 2018; 55: 788-791
- Position paper update: whole bowel irrigation for gastrointestinal decontamination of overdose patients.Clin Toxicol (Phila). 2015; 53: 5-12
- Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.Clin Toxicol (Phila). 2018; 56: 404-411
- Analysis and clinical findings of cases positive for thenovel synthetic cannabinoid receptor agonist MDMB-CHMICA.Clin Toxicol (Phila). 2016; 54: 632-637
Article info
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Nacca et al. In Reply to McCann et al.Journal of Emergency MedicineVol. 57Issue 3
